| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/1997 | US5620874 Incubation; antihelminthic utility |
| 04/15/1997 | US5620871 Process for preparing optionally hydrogenated indigestible polysaccharides |
| 04/15/1997 | US5620864 Acceptor for fucosyl transferase |
| 04/15/1997 | US5620705 Hormone replacement therapy tablet having drug layer with progesterone, sodium croscarmellose, polyoxyethylene glycol stearate, hydroxypropyl methyl cellulose, mannitol; displacement layer of sodium chloride, cellulose derivatives |
| 04/15/1997 | US5620703 Liposome-encapsulated antitumor,-carcinogenic agents; viricides; leukopenia |
| 04/15/1997 | US5620702 Adhesive bandages, wound dressings, sutures, drapes orthodontic rubber bands, toothbrushes, and the like |
| 04/15/1997 | US5620701 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 04/15/1997 | US5620699 Method for delivering nonaqueous fluorinated drug delivery vehicle suspensions |
| 04/15/1997 | US5620680 Contains atleast one ultraviolet radiation screening agent selected from 3-bezylidenecamphors, 4-aminobenzoic acids, esters of cinnamic and salicylic acids, benzophenones, triazines, and diones; oxidation resistance |
| 04/15/1997 | US5620416 Methods of using topical agents with systemically administered active agents |
| 04/15/1997 | CA2110410C Therapeutic compositions for osteoinduction |
| 04/15/1997 | CA2104576C A method for the treatment of tumours and sarcomas |
| 04/15/1997 | CA2104229C Opiate receptor antagonist modulates movement disorder |
| 04/15/1997 | CA2067221C Fused pyrimidine derivative, process for preparation of same and pharmaceutical preparation comprising same as active ingredient |
| 04/15/1997 | CA2006398C Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012985A2 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 04/10/1997 | WO1997012979A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | WO1997012970A1 Antitumour vector constructs and methods |
| 04/10/1997 | WO1997012969A2 Fmr1-related protein |
| 04/10/1997 | WO1997012967A1 Antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for replication |
| 04/10/1997 | WO1997012904A1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012901A1 Process for isolating immunoglobulins in whey |
| 04/10/1997 | WO1997012898A1 Novel platelet activation protein |
| 04/10/1997 | WO1997012894A1 Preparation of glucosaminyl muramic acid derivatives |
| 04/10/1997 | WO1997012892A1 SYNTHETIC MULTIVALENT sLEX CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 04/10/1997 | WO1997012891A1 Polymeric platinum complex, preparation thereof, and anticancer agent comprising thereof |
| 04/10/1997 | WO1997012890A1 New cephem compounds |
| 04/10/1997 | WO1997012889A1 Penicillin glycolate |
| 04/10/1997 | WO1997012888A1 Purine and guanine derivatives |
| 04/10/1997 | WO1997012887A1 Purine and guanine derivatives as pnp inhibitors |
| 04/10/1997 | WO1997012880A1 Pyrimidine derivatives as 5ht2c-receptor antagonists |
| 04/10/1997 | WO1997012878A1 Amino acid derivatives, the preparation and use thereof as endothelin antagonists |
| 04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/10/1997 | WO1997012874A1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 04/10/1997 | WO1997012870A1 Tetrahydroquinolines as nmda antagonists |
| 04/10/1997 | WO1997012868A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori |
| 04/10/1997 | WO1997012867A1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 04/10/1997 | WO1997012862A1 Cbi analogs of cc-1065 and the duocarmycins |
| 04/10/1997 | WO1997012859A1 Succinimide and maleimide cytokine inhibitors |
| 04/10/1997 | WO1997012858A1 PROCESS FOR PRODUCING N-(D-α-METHYL-β-MERCAPTOPROPIONYL)-L-PROLINE AND INTERMEDIATES THEREOF |
| 04/10/1997 | WO1997012855A1 Butyrate prodrugs of lactic acid |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012852A1 Semi-fluorinated alkanes and their use |
| 04/10/1997 | WO1997012639A1 Medicament inhaler |
| 04/10/1997 | WO1997012634A1 A NOVEL COMBINATION OF A β-RECEPTOR BLOCKER AND AN OPIOID |
| 04/10/1997 | WO1997012633A1 Dendritic cell stimulatory factor |
| 04/10/1997 | WO1997012630A1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer |
| 04/10/1997 | WO1997012627A1 Therapeutic administration of hemoglobin in cardiac arrest |
| 04/10/1997 | WO1997012626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation |
| 04/10/1997 | WO1997012623A1 Methods and compositions for viral enhancement of cell killing |
| 04/10/1997 | WO1997012621A1 Cellulose sulfate for use as antimicrobial and contraceptive agent |
| 04/10/1997 | WO1997012620A1 Method and composition for treatment of osteoporosis |
| 04/10/1997 | WO1997012619A1 Method of treating the navicular disease in horses |
| 04/10/1997 | WO1997012618A1 Gel for the local hormonotherapy of vaginal dryness |
| 04/10/1997 | WO1997012617A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | WO1997012616A1 Drug for treating glaucoma |
| 04/10/1997 | WO1997012615A1 Benzimidazole derivatives as 15-lo inhibitors |
| 04/10/1997 | WO1997012614A1 Administration by inhalation of 2-amino-6n-propylamino-4,5,6,7-tetrahydrobenzothiazol, in particular of its (-)enantiomer and its pharmacologically tolerable acid addition salts |
| 04/10/1997 | WO1997012613A1 Method for treating and preventing inflammation and atherosclerosis |
| 04/10/1997 | WO1997012612A1 Compositions of melatonin and analgetic agents and methods of use thereof |
| 04/10/1997 | WO1997012611A1 Treatment of atherosclerosis |
| 04/10/1997 | WO1997012610A2 Use of vitamins e and c |
| 04/10/1997 | WO1997012609A1 Reduction of glutamate neurotoxicity |
| 04/10/1997 | WO1997012608A1 External antiinflammatory agent |
| 04/10/1997 | WO1997012603A1 Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt |
| 04/10/1997 | WO1997012602A1 Stimulation of hair follicles |
| 04/10/1997 | WO1997012601A2 Gel formulations containing growth factors |
| 04/10/1997 | WO1997012600A1 Unit galenical form for local hormonotherapy of vaginal dryness |
| 04/10/1997 | WO1997012597A1 Use of carbohydrates for promoting skin exfoliation |
| 04/10/1997 | WO1997012596A1 Hair care composition including at least one silicone polymer grafted by anionic, amphoteric or non-ionic monomers, and at least one amphoteric polymer |
| 04/10/1997 | WO1997012591A1 Skin-care agent for ageing skin |
| 04/10/1997 | WO1997012590A1 ULTRAVIOLET-PROTECTING COSMETIC COMPOSITIONS CONTAINING TiO2 NANOPIGMENTS AND AN ACYLAMINOACID |
| 04/10/1997 | WO1997012583A2 Stable compositions containing n-propargyl-1-aminoindan |
| 04/10/1997 | WO1997012582A2 Method for preventing and treating coccidiosis |
| 04/10/1997 | WO1997012581A2 Novel composition containing an acid-labile omeprazole and process for its preparation |
| 04/10/1997 | WO1997012580A2 Novel composition containing an acid-labile benzimidazole and process for its preparation |
| 04/10/1997 | WO1997012527A2 Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | WO1997012521A1 Antiparasitic composition for treating and protecting pets |
| 04/10/1997 | WO1997009998A3 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 04/10/1997 | WO1997006798A3 Pharmaceutical formulations |
| 04/10/1997 | WO1997005250A3 Receptor ligand vegf-c |
| 04/10/1997 | WO1997002830A3 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 04/10/1997 | DE19537548A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
| 04/10/1997 | DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs. |
| 04/10/1997 | DE19537027A1 Hautpflegemittel für alte Haut Skin care products for old skin |
| 04/10/1997 | DE19537012A1 Cyclosporin(e) enhaltende pharmazeutische Zubereitung zur oralen Applikation und Verfahren zu ihrer Herstellung A cyclosporin (s) enhaltende pharmaceutical preparation for oral administration and processes for their preparation |
| 04/10/1997 | DE19536916A1 Inhalative Applikation von 2-Amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol, insbesondere seines (-)-Enantiomeren, sowie deren pharmakologisch verträgliche Säureadditionssalze Administration by inhalation of 2-amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole, particularly its (-) - enantiomers, as well as their pharmacologically acceptable acid addition salts |
| 04/10/1997 | DE19536891A1 Neue Aminosäurederivate, ihre Herstellung und Verwendung New amino acid derivatives, their preparation and use |
| 04/10/1997 | DE19534602A1 Verwendung von Threonin zur Behandlung der Phenylketonurie Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | CA2234229A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | CA2234061A1 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | CA2234060A1 Methods and compositions for viral enhancement of cell killing |
| 04/10/1997 | CA2234045A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | CA2233994A1 Novel platelet activation protein |
| 04/10/1997 | CA2233936A1 Cbi analogs of cc-1065 and the duocarmycins |
| 04/10/1997 | CA2233935A1 Process for isolating immunoglobulins in whey |
| 04/10/1997 | CA2233923A1 Gel for the local hormonotherapy of vaginal dryness |